These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38134445)

  • 1. AMALPHI: A Machine Learning Platform for Predicting Drug-Induced PhospholIpidosis.
    Lomuscio MC; Abate C; Alberga D; Laghezza A; Corriero N; Colabufo NA; Saviano M; Delre P; Mangiatordi GF
    Mol Pharm; 2024 Feb; 21(2):864-872. PubMed ID: 38134445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
    Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
    Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier.
    Yang L; Zhong X; Li Q; Zhang X; Wang Y; Yang K; Zhang LW
    Toxicol Sci; 2017 Mar; 156(1):39-53. PubMed ID: 28013220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting ensemble learning to improve prediction of phospholipidosis inducing potential.
    Nath A; Sahu GK
    J Theor Biol; 2019 Oct; 479():37-47. PubMed ID: 31310757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
    van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG
    Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A machine learning and live-cell imaging tool kit uncovers small molecules induced phospholipidosis.
    Hu H; Tjaden A; Knapp S; Antolin AA; Müller S
    Cell Chem Biol; 2023 Dec; 30(12):1634-1651.e6. PubMed ID: 37797617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALPACA: A machine Learning Platform for Affinity and selectivity profiling of CAnnabinoids receptors modulators.
    Delre P; Contino M; Alberga D; Saviano M; Corriero N; Mangiatordi GF
    Comput Biol Med; 2023 Sep; 164():107314. PubMed ID: 37572442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone.
    Natale A; Boeckmans J; Desmae T; De Boe V; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
    Toxicol Lett; 2018 Mar; 284():184-194. PubMed ID: 29248575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the Risk of Phospholipidosis with in Silico Models and an Image-Based in Vitro Screen.
    Fusani L; Brown M; Chen H; Ahlberg E; Noeske T
    Mol Pharm; 2017 Dec; 14(12):4346-4352. PubMed ID: 29077420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of drugs inducing phospholipidosis by novel in vitro data.
    Muehlbacher M; Tripal P; Roas F; Kornhuber J
    ChemMedChem; 2012 Nov; 7(11):1925-34. PubMed ID: 22945602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the accumulation of fluorescently labeled phospholipids in cell cultures provides an accurate screen for drugs that induce phospholipidosis.
    Nioi P; Pardo ID; Snyder RD
    Drug Chem Toxicol; 2008; 31(4):515-28. PubMed ID: 18850360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting phospholipidosis using machine learning.
    Lowe R; Glen RC; Mitchell JB
    Mol Pharm; 2010 Oct; 7(5):1708-14. PubMed ID: 20799726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome electrokinetic chromatography based in vitro model for early screening of the drug-induced phospholipidosis risk.
    Wang T; Feng Y; Jin X; Fan X; Crommen J; Jiang Z
    J Pharm Biomed Anal; 2014 Aug; 96():263-71. PubMed ID: 24814828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the phospholipidogenic potential of 4(1H)-pyridone antimalarial derivatives.
    Almela MJ; Torres PA; Lozano S; Herreros E
    Toxicol In Vitro; 2009 Dec; 23(8):1528-34. PubMed ID: 19540329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Assessment of Drug Delivery to Tissues and Association with Phospholipidosis: A Case Study with Two Structurally Related Diamines in Development.
    Loryan I; Hoppe E; Hansen K; Held F; Kless A; Linz K; Marossek V; Nolte B; Ratcliffe P; Saunders D; Terlinden R; Wegert A; Welbers A; Will O; Hammarlund-Udenaes M
    Mol Pharm; 2017 Dec; 14(12):4362-4373. PubMed ID: 29099189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.
    Tummino TA; Rezelj VV; Fischer B; Fischer A; O'Meara MJ; Monel B; Vallet T; White KM; Zhang Z; Alon A; Schadt H; O'Donnell HR; Lyu J; Rosales R; McGovern BL; Rathnasinghe R; Jangra S; Schotsaert M; Galarneau JR; Krogan NJ; Urban L; Shokat KM; Kruse AC; García-Sastre A; Schwartz O; Moretti F; Vignuzzi M; Pognan F; Shoichet BK
    Science; 2021 Jul; 373(6554):541-547. PubMed ID: 34326236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes.
    Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell-based assay using HepaRG cells for predicting drug-induced phospholipidosis.
    Tomida T; Ishimura M; Iwaki M
    J Toxicol Sci; 2017; 42(5):641-650. PubMed ID: 28904299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro validation of drug-induced phospholipidosis.
    Park S; Choi YJ; Lee BH
    J Toxicol Sci; 2012; 37(2):261-7. PubMed ID: 22467016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.